Mitsui Fudosan Co Ltd
TSE:8801
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Mitsui Fudosan Co Ltd
TSE:8801
|
JP |
|
Journey Medical Corp
NASDAQ:DERM
|
US |
|
N
|
Nippon Yusen KK
XMUN:NYKA
|
JP |
|
G
|
Glaukos Corp
F:6GJ
|
US |
|
Compagnie Financiere Richemont SA
SIX:CFR
|
CH |
|
Ascendis Pharma A/S
NASDAQ:ASND
|
DK |
|
P
|
Phunware Inc
SWB:2RJ
|
US |
|
J
|
Juniper Networks Inc
F:JNP
|
US |
Wall St Price Targets
Price Targets Summary
Mitsui Fudosan Co Ltd
According to Wall Street analysts, the average 1-year price target for Mitsui Fudosan Co Ltd is 2 123.95 JPY with a low forecast of 1 717 JPY and a high forecast of 2 698.5 JPY.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Mitsui Fudosan Co Ltd's stock price target?
Price Target
2 123.95
JPY
According to Wall Street analysts, the average 1-year price target for Mitsui Fudosan Co Ltd is 2 123.95 JPY with a low forecast of 1 717 JPY and a high forecast of 2 698.5 JPY.
What is the Revenue forecast for Mitsui Fudosan Co Ltd?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 4%.
What is the Gross Profit forecast for Mitsui Fudosan Co Ltd?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 3 years is 5%.
What is the Pre-Tax Income forecast for Mitsui Fudosan Co Ltd?
Projected CAGR
-2%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is -2%.
What is the Net Income forecast for Mitsui Fudosan Co Ltd?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 3 years is 5%.
